Diligent Pharma

Diligent Pharma, Inc. is a Princeton, New Jersey clinical-trial quality and compliance company, founded in 2015, that operates a centralized vendor qualification and oversight platform for pharmaceutical and biotech sponsors and their service providers. Its Diligent360 platform unifies the vendor lifecycle — AI-assisted discovery across a network of 2,000+ clinical vendors, capability evaluation through standardized questionnaires, risk scoring across quality, compliance, cybersecurity and AI risk domains, qualification against ICH E6(R3) and GxP expectations, and ongoing oversight monitoring. Companion products DiligentRespond (automated vendor questionnaire response) and DiligentQualified (qualification package management) sit alongside a GxP audit services practice. The company raised an $8.27M Series A led by FCA Venture Partners in 2023 and has appeared on the Inc. 5000 list. The platform is delivered as an authenticated web application at 360.diligentpharma.com; Diligent Pharma publishes no public developer program, API reference, or machine-readable specification.

Diligent Pharma is profiled on the APIs.io network. Tagged areas include Company, Clinical Trials, Life Sciences, Pharmaceuticals, and Biotechnology.

Diligent Pharma’s developer surface includes support, engineering blog, authentication, and 15 more developer resources.

24.8/100 emerging ▬ flat Agent 12/100 agent aware Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyClinical TrialsLife SciencesPharmaceuticalsBiotechnologyVendor ManagementRisk ManagementQuality ManagementComplianceGxPAuditingSaaS

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 24.8/100 · emerging
Contract Quality 0.0 / 21
Developer Ergonomics 3.0 / 17
Commercial Clarity 7.2 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 5.8 / 9
Regulatory Posture 8.8 / 15
Agent readiness — 12/100 · agent aware
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 10 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 7 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/diligent-pharma: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Pricing Plans 1

Published pricing tiers and plan structures.

Rate Limits 1

Documented rate limits and quota policies.

Diligent Pharma Rate Limits

0 limits

RATE LIMITS

Security Posture 3

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Diligent Pharma Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Diligent Pharma Trust Center

trust center published

SECURITY

Scopes 1

OAuth scopes governing access to this provider's APIs.

Diligent Pharma Scopes

OAuth 2.0 · no documented scopes

0 scopes

SCOPES

Resources

Get Started 1

Portal, sign-up, and the first successful call

Agent Surfaces 2

MCP servers, agent skills, and machine-readable catalogs

Design & Contract 2

Pagination, idempotency, versioning, errors, and events

Access & Security 4

Authentication, authorization, and security posture

Operate 3

Status, limits, changes, and where to get help

Commercial 3

Pricing, plans, and the legal terms of use

Company 3

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: diligent-pharma
name: Diligent Pharma
description: Diligent Pharma, Inc. is a Princeton, New Jersey clinical-trial quality and compliance company, founded in 2015,
  that operates a centralized vendor qualification and oversight platform for pharmaceutical and biotech sponsors and their
  service providers. Its Diligent360 platform unifies the vendor lifecycle — AI-assisted discovery across a network of 2,000+
  clinical vendors, capability evaluation through standardized questionnaires, risk scoring across quality, compliance, cybersecurity
  and AI risk domains, qualification against ICH E6(R3) and GxP expectations, and ongoing oversight monitoring. Companion
  products DiligentRespond (automated vendor questionnaire response) and DiligentQualified (qualification package management)
  sit alongside a GxP audit services practice. The company raised an $8.27M Series A led by FCA Venture Partners in 2023 and
  has appeared on the Inc. 5000 list. The platform is delivered as an authenticated web application at 360.diligentpharma.com;
  Diligent Pharma publishes no public developer program, API reference, or machine-readable specification.
url: https://raw.githubusercontent.com/api-evangelist/diligent-pharma/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profile
x-tier-reason: enrichment
specificationVersion: '0.20'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Clinical Trials
- Life Sciences
- Pharmaceuticals
- Biotechnology
- Vendor Management
- Risk Management
- Quality Management
- Compliance
- GxP
- Auditing
- SaaS
image: https://framerusercontent.com/images/IVa30WHEF9tH1ceuGsXZVst1kLM.png
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/diligent-pharma-domain-security.yml
- type: Website
  url: https://www.diligentpharma.com/
- type: Login
  url: https://360.diligentpharma.com/
- type: Support
  url: https://support.diligentpharma.com/hc/en-us
- type: Blog
  url: https://www.diligentpharma.com/resources
- type: TermsOfService
  url: https://www.diligentpharma.com/website-terms-of-use
- type: PrivacyPolicy
  url: https://www.diligentpharma.com/privacy-policy
- type: TrustCenter
  url: security/diligent-pharma-trust-center.yml
- type: LinkedIn
  url: https://www.linkedin.com/company/diligentpharma
- type: Contact
  url: https://www.diligentpharma.com/contact-us
- type: WellKnown
  url: well-known/diligent-pharma-well-known.yml
- type: Authentication
  url: authentication/diligent-pharma-authentication.yml
- type: OAuthScopes
  url: scopes/diligent-pharma-scopes.yml
- type: Conformance
  url: conformance/diligent-pharma-conformance.yml
- type: Lifecycle
  url: lifecycle/diligent-pharma-lifecycle.yml
- type: Plans
  url: plans/diligent-pharma-plans-pricing.yml
- type: RateLimits
  url: rate-limits/diligent-pharma-rate-limits.yml
- type: LLMsTxt
  url: llms/diligent-pharma-llms.txt
x-enrichment:
  date: '2026-08-12'
  status: minimal
  artifacts_added: 14
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: Diligent Pharma ships Diligent360 only as an authenticated end-user web app — api., docs. and developer.diligentpharma.com
    do not resolve, and 360.diligentpharma.com is a create-react-app SPA that answers 200 with the same 1,205-byte HTML shell
    for /openapi.json, /swagger.json, /llms.txt and every /.well-known/ path, so none of those 200s is a document.
  evidence:
  - url: https://docs.diligentpharma.com/
    status: 0
  - url: https://api.diligentpharma.com/
    status: 0
  - url: https://360.diligentpharma.com/openapi.json
    status: 200
  - url: https://www.diligentpharma.com/.well-known/security.txt
    status: 404
  - url: https://clerk.diligentpharma.com/.well-known/openid-configuration
    status: 200
  checked: '2026-08-12'